The Drug-Induced Respiratory Disease Website and App

E-cigarette - E-vaporizers - ENDS - Vaping - Dabbing

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

III.m

Coagulopathy

Publications

Kopsombut G, Ajjegowda A, Livingston F, Epelman M, Brown B, Werk L, Brogan R

Clinical Findings in Adolescents Hospitalized With EVALI; Novel Report on Coagulopathy.

Hospital pediatrics. 2022;12(2):229-240

Harada HA, Liu J, Shortell JD, Beesley SJ

A 20-Year-Old Man with e-Cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and Thrombotic Coagulopathy.

The American journal of case reports. 2021;22:e929915

Hiramatsu K, Kamei S, Sugimoto M, Kinoshita K, Iwasaki K, Kawakita M

An improved method of determining free and acetylated polyamines by HPLC involving an enzyme reactor and an electrochemical detector.

Journal of biochemistry. 1994;115(3):584-9